Explore UAB
Hugh Kaul Precision Medicine Institute • November 18, 2026

Dr. Matt Might delivers the keynote address at UAB Diabetes Research DayArtificial intelligence (AI) is creating new opportunities to understand disease, identify potential treatments, and advance personalized medicine. At UAB Diabetes Research Day, Matt Might, Ph.D., director of the Hugh Kaul Precision Medicine Institute, explored how these emerging technologies could help transform diabetes research and care.

In his keynote address, “Precision Diabetes in the Age of AI: What Rare Disease Taught Us, and What Comes Next,” Might drew on his experience applying computer science and AI to complex medical challenges to discuss the potential for more individualized approaches to diabetes.

Might, who is also a senior scientist in the UAB Comprehensive Diabetes Center, shared how his personal experience as a father of a child with a rare genetic condition led him to pursue precision medicine. That journey helped inspire the development of computational approaches that connect scientific research with patient data to identify potential treatment opportunities.

Building on that work, Might discussed how AI could help researchers better understand the biological differences among people with diabetes. These approaches could help identify distinct disease subtypes and provide insight into how individual patients may respond to treatment. He also discussed the potential for AI to improve clinical trial matching.

“Intelligence used to be scarce. It's not scarce anymore. Intelligence is abundant,” Might said, describing the rapid pace of AI development and its potential to accelerate scientific discovery.

Might also emphasized that realizing AI's potential in medicine requires careful oversight. Models must be continually evaluated to ensure they are accurate and applicable to the patient populations they are intended to serve. Patient privacy and responsible use of medical data remain essential.

As AI continues to expand what's possible in research, Might encouraged researchers to remain curious and pursue new opportunities for collaboration. Ultimately, the goal is to translate these technological advances into discoveries that benefit patients.


Subscribe to Heersink
School of Medicine News

Subscribe to Heersink School of Medicine News